Европейски съюз -
италиански -
EMA (European Medicines Agency)
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibatterici per uso sistemico, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. dovrebbero essere prese in considerazione le linee guida ufficiali sull'uso appropriato degli agenti antibatterici..
Европейски съюз -
италиански -
EMA (European Medicines Agency)
ovugel
vetoquinol - triptorelin acetate - ormoni ipofisari e ipotalamici e analoghi - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.
Европейски съюз -
италиански -
EMA (European Medicines Agency)
icatibant accord
accord healthcare s.l.u. - icatibant acetate - angioedema, ereditario - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.
Европейски съюз -
италиански -
EMA (European Medicines Agency)
ganirelix gedeon richter
chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).
Европейски съюз -
италиански -
EMA (European Medicines Agency)
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegalia - ormoni ipofisari e ipotalamici e analoghi - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
Европейски съюз -
италиански -
EMA (European Medicines Agency)
degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
Италия -
италиански -
Ministero della Salute
estropill
intervet productions srl - megestrolo acetato - megestrolo acetato - 2 grammo (i), megestrolo acetato - 9.2 milligrammo (i), megestrolo acetato - 5 milligrammo (i), megestrolo acetato - 2 g, megestrolo acetato - 5 mg, megestrolo acetato - 9.2 mg - megestrol
Италия -
италиански -
Ministero della Salute
neurofisin
fatro s.p.a. - ossitocina acetato - ossitocina acetato - 10 unit? internazionali, ossitocina acetato - 10 unit? internazionali, ossitocina acetato - 10 unit? internazionali, ossitocina acetato - 10 unit? internazionali, ossitocina acetato - 10 unit? internazionali, ossitocina acetato - 10 ui - oxytocin